StockWatch
·

Cholamandalam Investment and Finance Company Ltd

BSE: 511243

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
9.4K
+4.9%+23.4%
Expenditure
7.2K
+6.9%+19.1%
Net Profit
1.6K
-1.4%+41.1%
OPM %
70.04%
-0.13pp+2.75pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.002.6K5.2K7.9K10.5KQ1 FY19Q2 FY19Q3 FY19Q4 FY19Q4 FY25Q1 FY26Q2 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Chola Q2 FY27: Consol PAT +41% YoY to ₹1,630 Cr on margin expansion, cools 2% QoQ

nbfc · vehicle finance · margin expansion

ResultsQ2 FY2728 Oct 20263 minFinancial Services

Chola FY27: Growth Momentum Under Valuation Pressure

NBFC · vehicle finance · mortgage

Result previewQ2 FY2722 Oct 20263 minFinancial Services

Record PAT growth masks cautious forward view — cost tailwinds may not repeat

AUM growth · credit costs · NIM expansion

Result verdictFollow-upQ1 FY2716 Aug 20266 minFinancial Services
Latest
Board Meeting28 Oct, 1:27 pm

Chola Q2 FY27: Consol PAT +41% YoY to ₹1,630 Cr on margin expansion, cools 2% QoQ

Cholamandalam Investment and Finance reported consolidated PAT of ₹1,630.34 Cr for Q2 FY27, up 40.6% year-on-year from ₹1,159.61 Cr, on consolidated revenue of ₹9,270.92 Cr (+23.75% YoY). Profit growth outpaced revenue growth, pushing net profit margin to 17.36% from 15.23% a year ago (standalone NPM 17.63% vs 15.47%, per the regulatory ratio disclosure). Sequentially the picture is softer: revenue rose 4.68% QoQ but PAT slipped 1.56% QoQ from Q1 FY27's ₹1,656.22 Cr, and NPM compressed from Q1's 18.49% — a normal give-back after an unusually strong opening quarter rather than a trend reversal, and YoY remains the primary read per house convention. Standalone and consolidated results are effectively identical (PAT differs by just ₹0.27 Cr), so there is no basis divergence to flag. The margin expansion sits on contained credit costs and improving asset quality rather than a one-off: impairment of financial instruments was ₹874.21 Cr, down from ₹922.06 Cr in Q1, while Gross Stage-3 (NPA) improved to 3.25% from 3.35% YoY and Net Stage-3 to 1.80% from 1.93% YoY, with provision coverage up to 45.32% from 43.23%. By segment, Vehicle Finance (PBT ₹979.17 Cr) and Loan Against Property (₹556.17 Cr) together drove the bulk of the ₹2,188.38 Cr segment PBT, with Home Loans contributing ₹269.02 Cr — consistent with the diversification thesis analysts have been tracking. The standalone loan book grew to ₹2,40,133.20 Cr from ₹2,17,571.16 Cr at FY26-end, a ~10.4% six-month rise that annualises close to the 23% FY27 AUM-growth guidance management gave on the Q1 concall; credit costs also look contained relative to the ~1.5% guided band, though the filing does not disclose a precise pre-tax ROA to check against the 3.5% minimum (Q1: 3.7%), so guidance delivery is assessed as broadly on-track rather than confirmed beat. No separate management press release was available in this filing to cross-check against the numbers. Against our pre-result preview, which flagged Street expectations of ~₹8,900–9,100 Cr revenue and ~₹18.85 EPS for the quarter, the actual consolidated revenue of ₹9,270.92 Cr and basic EPS of ₹19.09 both came in above the expected range — a beat on both counts. Capital adequacy improved to 20.62% from 20.00% YoY even before the board's same-day approval of a QIP to raise up to ₹5,000 Cr, and the quarter also saw conversion of the remaining CCDs into 30.55 lakh equity shares and allotment of ₹2,000 Cr of perpetual NCDs — both consistent with the company funding its stated growth plan. The prior concall's cautious tone centered on cost-of-funds neutrality assuming a 25–50 bps RBI rate hike and holding credit costs near 1.5%; this quarter's contained impairment charge and improved NPA ratios are broadly consistent with that script. Going forward, the QIP pricing and resulting dilution will be the next event to track against the EPS trajectory just established. The sequential NPM compression (18.49% to 17.36% consolidated) bears watching next quarter to confirm it was Q1 seasonality rather than the start of a trend, and the loan book's annualised growth pace needs to hold near the 23% FY27 target for guidance to be called fully met rather than merely on-track.

28 Oct 2026, 01:27 pm

Corporate Events

Board MeetingCHOLAFIN
2026
28Oct

Board Meeting

A meeting of the Board of Directors of the Company is schedu…

BSE Filing ↗
Board MeetingCHOLAFIN
2026
28Jul

Board Meeting

The Board will consider the issuance of non-convertible debe…

BSE Filing ↗
Board MeetingCHOLAFIN
2026
28Jul

Board Meeting

The 48th Annual General Meeting (AGM) will be held through V…

BSE Filing ↗
DividendCHOLAFIN
2026
21Jul

₹0.7 / share

BSE Filing ↗
Board MeetingCHOLAFIN
2026
30Apr

Board Meeting

To consider and approve the audited standalone and consolida…

BSE Filing ↗
DividendCHOLAFIN
2026
5Feb

₹1.3 / share

BSE Filing ↗
Board MeetingCHOLAFIN
2024
25Oct

Board Meeting

Consideration And Approval Of The Unaudited Financials For T…

BSE Filing ↗
Board MeetingCHOLAFIN
2024
26Jul

Board Meeting

consider and approve the unaudited standalone and consolidat…

BSE Filing ↗
Board MeetingCHOLAFIN
2024
30Apr

Board Meeting

Consideration and approval of audited financial results for …

BSE Filing ↗
DividendCHOLAFIN
2024
7Feb

₹1.3 / share

BSE Filing ↗
Board MeetingCHOLAFIN
2024
25Jan

Board Meeting

consider and approve the unaudited standalone and consolidat…

BSE Filing ↗
Board MeetingCHOLAFIN
2023
2Nov

Board Meeting

Consider and approve the unaudited results for the quarter a…

BSE Filing ↗